SOM Biotech and Vall d’Hebron successfully complete a clinical trial in patients with TTR amyloidosis Blog Post

SOM Biotech and the Vall d’Hebron Research Institute (VHIR) have successfully completed a Phase IIa proof-of-concept clinical trial in humans to evaluate the efficacy and safety of an innovative oral therapy for transthyretin amyloidosis (TTA), a rare disease that affects the peripheral nervous system and heart. To carry out this trial, the hospital and the Catalan biotech, with headquarters at the Barcelona Science Park (PCB), signed an risk-sharing agreement under (RSA) which they jointly assumed the risks and economic returns of the project.

 

IBEC success in Human Brain Project funding call Blog Post

A study involving IBEC group leader and ICREA research professor Pau Gorostiza has been chosen for funding under a Call for Expressions of Interest (CEol) on Systems and Cognitive Neuroscience by the Human Brain Project (HBP) FET Flagship. Thanks to their success in this Call, the project partners – including IBEC – will be integrated in the broader HBP Consortium. 

 

Spain and France join the European Consortium Elixir for managing and analysing biological data Blog Post

At their meeting today in Hinxton (UK), the Board unanimously accepted Spain and France as full members of Elixir, the largest infrastructure of life science data in Europe. The National Bioinformatics Institute (INB), which acts as the Spanish scientific node, will coordinate the Spanish scientific partner institutions. These comprise top-level institutions such as CNAG-CRG and IRB Barcelona, located at PCB. The National Institute of Health Carlos III (ISCII) will coordinate the Spanish scientific partner institutions.

 

Artax is granted 10 million dollars to foster clinical trials with an innovative drug in patients who suffer from autoimmune disorders Blog Post

The start-up Artax Biopharma –focusing on the development of first-in-class drugs to treat autoimmune diseases- has closed a Series B series investment funding round totaling $10 Million to boost clinical trials of its most advanced compound, drug AX- 024. This biotech- based in Cambridge (Massachusetts) and founded by Damià Tormo, a scientist and entrepreneur from Valencia– leads a team in Spain that manages a large part of the project in Europe from its offices located in Valencia and at Barcelona Science Park (PCB). 

 

Researchers at IBEC and UAB have found a mycobacterium that is more effective in treating superficial bladder cancer Blog Post

Researchers from Institute for Bioengineering of Catalonia (IBEC), at Barcelona Science Park (PCB), with the Mycobacteria Research Group of the Department of Genetics and Microbiology, at Universitat Autònoma de Barcelona (UAB), have found a mycobacterium that is more effective in treating superficial bladder cancer and does not cause infections, unlike those used up to now. 

 

Leitat leads GLAM, a European project to improve cancer diagnosis Blog Post

A European consortium led by Centre Tecnològic Leitat –through its Biomed Divisionlocated at the Barcelona Science Park (PCB)– has started the Glass-Laser Multiplexed Biosensor (GLAM) project, the aim of which is to develop a photonic-based point-of-care device for a non-invasive diagnosis of Genitourinary Cancer (GU). The GLAM project which will expand for 4 years will involve the participation of 10 European organizations with resources and capabilities from the academia and scientific and business field, among them the Institute for Bioengineering of Catalonia (IBEC), located at PCB. 

 

Atrian Bakers’s bread Tritordeum, made with the new cereal Agrasys, nominated to the Carrefour Innovation Awards Blog Post

A new type of bread  produced by Atrian Bakers  and made with Tritordeum,  has been nominated for the 2015 Carrefour Innovation Awards. The new type of bread will be subjected to population vote until the 21st of June. Tritordeum cereal is the first man-made cereal without genetic modification suitable for human consumption. Developed in the late 70s by a group of scientists from the Institute for Sustainable Agriculture (IAS) of the Higher Council for Scientific Research (CSIC)), and after 30 years of research, Agrasys -a spin-off company based at the Barcelona Science Park, founded by researchers from the IAS and the industry, launched the new bread to the market in April 2013.

AWS Truepower takes part in the WindPower American Wind Energy Association fair Blog Post

One more time, AWS Truepower, one of the world’s leading consultancy firms in the field of renewables energies, is present at the Windpower fair of the American Wind Energy Association (AWEA) that is starting today and will run until Thursday at the Orange County Convention Center in Orlando (Florida). The subsidiary company for Europe and Latin America –AWS Truepower SLU– is based at the Parc Cientific de Barcelona (PCB).